{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:15:39Z","timestamp":1793502939995,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:p>Left ventricular assist devices (LVADs) are widely used as end-stage therapy in patients with advanced heart failure, whereas implantation increases the risks of development of sustained ventricular tachycardia at the later postimplantation stage. Therefore, this study aimed to evaluate the clinical efficacy of orally administered amiodarone and propranolol in 3 patients with ventricular tachycardia (VT) after LVAD implantation who were resistant to initial anti-antiarrhythmic drugs. This retrospective cohort study consisted of the initial evaluation of the clinical data of 14 adult patients who underwent implantation of LVAD between January 2019 and March 2021. A total of 3 patients with resistant VT were finally included. In all cases, the patients were initially administered amiodarone in the different doses intravenously to stabilize the critical condition, whereas its oral form along with that of propranolol was used as maintenance therapy in the first 2 cases. In the third case, amiodarone was withdrawn because of the risk of development of hyperthyroidism, while oral propranolol was used in the treatment. The assessment in the 16-month follow-up period after discharge did not show presence of non-sustained and sustained VT in all 3 cases. In the ventricular arrhythmia-free group, the total mortality rate within the follow-up period was 11.1\u2005\u00b1\u20057.78 months in the 3 patients. We suggest that maintenance oral therapy of propranolol and amiodarone can significantly decrease the risks of complications in patients with VT after implantation of ventricular assist device in the long term.<\/jats:p>","DOI":"10.1097\/md.0000000000038839","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:09:03Z","timestamp":1720796943000},"page":"e38839","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Oral amiodarone and propranolol in maintenance therapy of postimplantation tachycardia: An observational study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2355-3524","authenticated-orcid":false,"given":"Abdulla","family":"Arslan","sequence":"first","affiliation":[{"name":"Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6yk\u00fc G\u00fclmez","family":"\u00d6zkaya","sequence":"additional","affiliation":[{"name":"Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Aytemiz","sequence":"additional","affiliation":[{"name":"Cardiology Department, Manisa State Hospital, Manisa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Altay","sequence":"additional","affiliation":[{"name":"Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin Evren","family":"\u00d6zcan","sequence":"additional","affiliation":[{"name":"Cardiology Department, Dokuz Eyl\u00fcl University Izmir Medical and Research Center, Bal\u00e7ova\/Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz S\u00fcha","family":"K\u00fc\u00e7\u00fckaksu","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedat","family":"Bakuy","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Kozan","sequence":"additional","affiliation":[{"name":"Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se\u00e7kin","family":"Pehlivano\u011flu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Baskent University Istanbul Medical and Research Center, Altunizade\/Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260204","first-page":"e4399","article-title":"Left ventricular assist device: what the internist needs to know. A review of the literature.","volume":"11","author":"Boruah","year":"2019","journal-title":"Cureus"},{"key":"R2-20260204","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.hrthm.2016.01.033","article-title":"Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device.","volume":"13","author":"Yoruk","year":"2016","journal-title":"Heart Rhythm"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCHEARTFAILURE.112.969873","article-title":"Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and non-pulsatile left ventricular assist devices.","volume":"6","author":"Markham","year":"2013","journal-title":"Circ Heart Fail"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1055\/s-0029-1240709","article-title":"Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin\u2013angiotensin system in patients with end-stage heart failure.","volume":"58","author":"Welp","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1253\/circj.CJ-14-1079","article-title":"Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events.","volume":"79","author":"Hasin","year":"2015","journal-title":"Circ J"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jacc.2010.10.062","article-title":"Results of the Post-U.S. food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).","volume":"57","author":"Starling","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.hrthm.2017.07.027","article-title":"Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study.","volume":"14","author":"Efimova","year":"2017","journal-title":"Heart Rhythm"},{"key":"R8-20260204","first-page":"58","article-title":"Sol Ventrik\u00fcl Destek Cihazi Olan Bir Hastada Ventrik\u00fcler Ta\u015fikardi Ablasyonu ablation of ventricular tachycardia in a patient with a left ventricular assist device.","volume":"48","author":"\u015eim\u015fek","year":"2020","journal-title":"Turk Kardiyol Dern Ars"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1540-8167.2011.02223.x","article-title":"Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.","volume":"23","author":"Brenyo","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacep.2017.11.001","article-title":"Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience.","volume":"4","author":"Greet","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator.","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jjcc.2021.12.009","article-title":"Late-Onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature.","volume":"80","author":"Hatano","year":"2022","journal-title":"J Cardiol"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1540-8159.2008.01173.x","article-title":"Ventricular arrhythmias after left ventricular assist device implantation.","volume":"31","author":"Refaat","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jacep.2017.05.012","article-title":"Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience.","volume":"3","author":"Moss","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"Suppl","key":"R15-20260204","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced HF.","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCHEARTFAILURE.111.963991","article-title":"Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.","volume":"5","author":"Park","year":"2012","journal-title":"Circ Heart Fail"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.resuscitation.2007.05.013","article-title":"Beta-Blockers for the treatment of cardiac arrest from ventricular fibrillation?","volume":"75","author":"Bourque","year":"2007","journal-title":"Resuscitation"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0002-8703(95)90354-2","article-title":"Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction.","volume":"130","author":"De Ferrari","year":"1995","journal-title":"Am Heart J"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","article-title":"Beta 1- and Beta 2-Adrenergic-Receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.","volume":"59","author":"Bristow","year":"1986","journal-title":"Circ Res"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/0002-9149(83)90368-5","article-title":"Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold.","volume":"51","author":"Anderson","year":"1983","journal-title":"Am J Cardiol"},{"key":"R21-20260204","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardfail.2004.08.158","article-title":"Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure.","volume":"11","author":"Harding","year":"2005","journal-title":"J Card Fail"},{"issue":"Suppl","key":"R22-20260204","doi-asserted-by":"crossref","first-page":"S500","DOI":"10.1054\/jcaf.2002.129264","article-title":"Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments.","volume":"8","author":"Margulies","year":"2002","journal-title":"J Card Fail"},{"key":"R23-20260204","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjcard.2006.11.051","article-title":"Ventricular arrhythmias during left ventricular assist device support.","volume":"99","author":"Bedi","year":"2007","journal-title":"Am J Cardiol"},{"key":"R24-20260204","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jacc.2005.01.035","article-title":"Effects of left ventricular assist device therapy on ventricular arrhythmias.","volume":"45","author":"Ziv","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R25-20260204","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/eurjhf\/hfq048","article-title":"Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients.","volume":"12","author":"Oswald","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R26-20260204","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R27-20260204","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.hrthm.2009.12.022","article-title":"Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator.","volume":"7","author":"Cantillon","year":"2010","journal-title":"Heart Rhythm"},{"key":"R28-20260204","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2012.06.018","article-title":"Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.","volume":"164","author":"Raasch","year":"2012","journal-title":"Am Heart J"},{"key":"R29-20260204","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1172\/JCI114510","article-title":"Suppression of ventricular arrhythmias in man by d-propranolol independent of betaadrenergic receptor blockade.","volume":"85","author":"Murray","year":"1990","journal-title":"J Clin Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:01:02Z","timestamp":1770213662000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":29,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038839","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}